Sodium-glucose cotransporter-2 inhibitors improve cardiovascular outcomes post-acute coronary syndrome complicated by acute heart failure (vol 11, 1383669, 2024)

被引:0
|
作者
Rahhal, Alaa [1 ]
Hamamyh, Tahseen [2 ]
Chapra, Ammar [2 ]
Zaza, Khaled J. [3 ]
Najim, Mostafa [4 ]
Hemadneh, Mohammad [5 ]
Faraj, Hazem [5 ]
Kanjo, Wael [5 ]
Yasin, Ahmed [5 ]
Toba, Haneen [5 ]
Mohammed, Wafa [5 ]
Hamad, Mohammad Khair [6 ]
Al-Tikrety, Nawras [5 ]
Habib, Mhd Baraa [2 ]
Awaisu, Ahmed [7 ]
Mahfouz, Ahmed [1 ]
Alyafei, Sumaya [1 ]
Arabi, Abdul Rahman [8 ]
Patel, Ashfaq [9 ]
Al-Hijji, Mohammed [8 ,10 ]
机构
[1] Hamad Med Corp, Pharm Dept, Doha, Qatar
[2] Hamad Med Corp, Cardiol Dept, Doha, Qatar
[3] Hamad Med Corp, Anesthesiol Intens Care & Perioperat Med Dept, Doha, Qatar
[4] Rochester Reg Hlth, Internal Med Dept, Rochester, NY USA
[5] Hamad Med Corp, Internal Med Dept, Doha, Qatar
[6] Hamad Med Corp, Endocrinol Dept, Doha, Qatar
[7] Qatar Univ, Dept Clin Pharm & Practice, Doha, Qatar
[8] Hamad Med Corp, Intervent Cardiol Dept, Doha, Qatar
[9] Hamad Med Corp, Heart Failure Dept, Doha, Qatar
[10] Weill Cornell Med, Dept Med, Doha, Qatar
来源
关键词
acute coronary syndrome; heart failure; sodium-glucose cotransporter-2 (SGLT-2) inhibitors; HF hospitalization; cardioprotection;
D O I
10.3389/fcvm.2025.1580343
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Sodium-glucose cotransporter-2 inhibitors in type 2 diabetes: a magic potion to reduce heart failure?
    Pafili, K.
    Papanas, N.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (08) : 693 - 695
  • [42] Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Body Composition and Fluid Status in Cardiovascular Rehabilitation Patients with Coronary Artery Disease and Heart Failure
    de la Flor, Jose C.
    Morales, Blanca Coto
    Basabe, Elena
    Hernandez, Maria Rey
    Gonzalez-Marino, Rocio Zamora
    Rodriguez Tudero, Celia
    Flores, Irwing Benites
    Espinoza, Carlos
    Terrones, Michael Cieza
    Guldris, Secundino Cigarran
    Vaquero, Jesus Hernandez
    MEDICINA-LITHUANIA, 2024, 60 (12):
  • [43] Association of sodium-glucose cotransporter 2 inhibitors with post-discharge outcomes in patients with acute heart failure with type 2 diabetes: a cohort study
    Sohee Park
    Han Eol Jeong
    Hyesung Lee
    Seng Chan You
    Ju-Young Shin
    Cardiovascular Diabetology, 22
  • [44] Association of sodium-glucose cotransporter 2 inhibitors with post-discharge outcomes in patients with acute heart failure with type 2 diabetes: a cohort study
    Park, Sohee
    Jeong, Han Eol
    Lee, Hyesung
    You, Seng Chan
    Shin, Ju-Young
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [45] Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)
    Kosiborod, Mikhail
    Cavender, Matthew A.
    Fu, Alex Z.
    Wilding, John P.
    Khunti, Kamlesh
    Holl, Reinhard W.
    Norhammar, Anna
    Birkeland, Kare I.
    Jorgensen, Marit Eika
    Thuresson, Marcus
    Arya, Niki
    Bodegard, Johan
    Hammar, Niklas
    Fenici, Peter
    CIRCULATION, 2017, 136 (03) : 249 - +
  • [46] Sodium-glucose cotransporter 2 inhibitors reduce cardiovascular events in acute heart failure. A real-world analysis
    Lopez-Vilella, Raquel
    Trenado, Victor Donoso
    Cervera, Borja Guerrero
    Sanchez-Lazaro, Ignacio
    Bonet, Luis Almenar
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 104 : 128 - 130
  • [47] Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors and Cardiovascular Outcomes in Patients with Diabetes Mellitus and Heart Failure
    Hofer, Felix
    Kazem, Niema
    Richter, Bernhard
    Sulzgruber, Patrick
    Schweitzer, Ronny
    Pailer, Ulrike
    Hammer, Andreas
    Koller, Lorenz
    Hengstenberg, Christian
    Niessner, Alexander
    CARDIOVASCULAR DRUGS AND THERAPY, 2022, 36 (03) : 497 - 504
  • [48] Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors and Cardiovascular Outcomes in Patients with Diabetes Mellitus and Heart Failure
    Felix Hofer
    Niema Kazem
    Bernhard Richter
    Patrick Sulzgruber
    Ronny Schweitzer
    Ulrike Pailer
    Andreas Hammer
    Lorenz Koller
    Christian Hengstenberg
    Alexander Niessner
    Cardiovascular Drugs and Therapy, 2022, 36 : 497 - 504
  • [50] The Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors on Cardiovascular Outcomes and All-Cause Mortality in Patients With Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
    Sinha, Tanya
    Khilji, Faria
    Laraib, Fnu
    Fatima, Farhana
    Kaur, Mandeep
    Chaudhari, Sandipkumar S.
    Agbor, Divine Besong Arrey
    Khan, Areeba
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)